SALIVARY GLAND CANCER STAGE III

This adverse event was reported 3 times

SALIVARY GLAND CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 1 0.0003
1 VERAPAMIL HYDROCHLORIDE 1 0.0002
2 ZONISAMIDE 1 0.0001
3 BASILIXIMAB 1 0.0001
4 SIROLIMUS 1 0.0001
5 LINACLOTIDE 1 0.0000
6 ERGOCALCIFEROL 1 0.0000
7 BIOTIN 1 0.0000
8 ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL 1 0.0000
9 TOPIRAMATE 1 0.0000
See all drugs enriched for association with SALIVARY GLAND CANCER STAGE III